Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Maintains Target Price $16.5
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Cuts Target Price to $16.5
Neogen Analyst Ratings
Piper Sandler Maintains Neutral on Neogen, Raises Price Target to $17.5
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $17.5
Neogen (NEOG) Gets a Hold From Piper Sandler
Neogen Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Argenx Se (ARGX), Neogen (NEOG) and Supernus Pharmaceuticals (SUPN)
Piper Sandler Maintains Neutral on Neogen, Raises Price Target to $19
Neogen Analyst Ratings
Piper Sandler Maintains Neutral on Neogen, Lowers Price Target to $17.5
Neogen Analyst Ratings
Wells Fargo Maintains Overweight on Neogen, Raises Price Target to $28
Neogen Analyst Ratings
Piper Sandler Keeps Their Hold Rating on Neogen (NEOG)
Neogen (NEOG) Has a New Rating From Wells Fargo
Wells Fargo Initiates Coverage On Neogen With Overweight Rating, Announces Price Target of $22
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Shockwave Medical (SWAV) and Neogen (NEOG)
Piper Sandler Adjusts Price Target on Neogen to $17 From $14, Maintains Neutral Rating
Neogen Analyst Ratings